{"id":4894,"date":"2018-07-03T07:25:22","date_gmt":"2018-07-03T11:25:22","guid":{"rendered":"https:\/\/www.stockcalc.com\/blog\/BrianD\/?p=4894"},"modified":"2018-07-03T07:25:22","modified_gmt":"2018-07-03T11:25:22","slug":"china-xd-plastics-co-cxdcnas-and-scpharmaceuticals-scphnas-trading-at-less-than-cash-value","status":"publish","type":"post","link":"https:\/\/www.stockcalc.com\/blog\/BrianD\/2018\/07\/03\/china-xd-plastics-co-cxdcnas-and-scpharmaceuticals-scphnas-trading-at-less-than-cash-value\/","title":{"rendered":"China XD Plastics Co (CXDC:NAS) and scPharmaceuticals (SCPH:NAS) Trading at Less than Cash Value"},"content":{"rendered":"

Stockcalc – Free Trial<\/h4>\n

Have a free look inside the StockCalc website at www.stockcalc.com<\/a><\/p>\n

\n
\n<\/hr>\n

I have used the analysis tools on the website stockcalc.com<\/a> to generate some of the content of this blog post. These tools and reports are available for free at www.stockcalc.com\/TopPicks.aspx<\/a>.<\/p>\n

Trading at Less than Cash Value<\/h4>\n

Today we are looking at companies trading at less than cash value<\/strong> meaning companies whose current share price is less than the cash per share on the balance sheet. We also show the value of cash net debt per share to show how much cash per share would be left if the debt was paid off.<\/p>\n

What this Means…<\/h5>\n

Companies can have more cash per share than the actual share price for a number of reasons including they just raised capital, are in industries that experience high burn rates and will eat through the cash quickly or if there is a lot of uncertainty about the future of the company. Companies earning a positive net income will have a P\/E greater than 0 and are worth exploring in more detail.<\/p>\n

Today’s Data on NASDAQ<\/h4>\n

Today’s data is for companies listed on the NASDAQ<\/strong>.<\/p>\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n
Symbol<\/th>\nName<\/th>\nClose Price<\/th>\nShares Outstanding<\/th>\nP\/E<\/th>\nP\/B<\/th>\nCash per Share<\/th>\nNet Cash per Share<\/th>\n<\/tr>\n
LEXEB<\/td>\nLiberty Expedia Holdings Inc<\/td>\n46.000000<\/td>\n57276000<\/td>\nNone<\/td>\n1.0232<\/td>\n61.86<\/td>\n-23.05<\/td>\n<\/tr>\n
LEXEA<\/td>\nLiberty Expedia Holdings Inc<\/td>\n43.800000<\/td>\n57276000<\/td>\nNone<\/td>\n0.9742<\/td>\n61.86<\/td>\n-23.05<\/td>\n<\/tr>\n
PDLI<\/td>\nPDL BioPharma Inc<\/td>\n2.320000<\/td>\n151640656<\/td>\n3.4118<\/td>\n0.4173<\/td>\n2.67<\/td>\n1.89<\/td>\n<\/tr>\n
CXDC<\/td>\nChina XD Plastics Co Ltd<\/td>\n3.300000<\/td>\n49727731<\/td>\n5.3226<\/td>\n0.2155<\/td>\n7.93<\/td>\n-8.55<\/td>\n<\/tr>\n
SCPH<\/td>\nscPharmaceuticals Inc<\/td>\n5.710000<\/td>\n18542334<\/td>\nNone<\/td>\n1.0810<\/td>\n5.89<\/td>\n5.37<\/td>\n<\/tr>\n
OPHT<\/td>\nOphthotech Corp<\/td>\n2.630000<\/td>\n36188161<\/td>\n0.6559<\/td>\n3.3898<\/td>\n4.28<\/td>\n5.82<\/td>\n<\/tr>\n
VSAR<\/td>\nVersartis Inc<\/td>\n2.000000<\/td>\n36081466<\/td>\nNone<\/td>\n0.9417<\/td>\n2.07<\/td>\n1.88<\/td>\n<\/tr>\n
GURE<\/td>\nGulf Resources Inc<\/td>\n1.400000<\/td>\n46803791<\/td>\n28.4000<\/td>\n0.1700<\/td>\n5.06<\/td>\n5.00<\/td>\n<\/tr>\n
ZAIS.DL<\/td>\nZAIS Group Holdings Inc<\/td>\n4.090000<\/td>\n14818332<\/td>\nNone<\/td>\n1.6296<\/td>\n4.09<\/td>\n3.41<\/td>\n<\/tr>\n
ASNS<\/td>\nArsanis Inc<\/td>\n4.000000<\/td>\n14294421<\/td>\nNone<\/td>\n1.1808<\/td>\n4.48<\/td>\n3.64<\/td>\n<\/tr>\n
AQXP<\/td>\nAquinox Pharmaceuticals Inc<\/td>\n2.260000<\/td>\n23508202<\/td>\nNone<\/td>\n0.6190<\/td>\n2.83<\/td>\n2.83<\/td>\n<\/tr>\n
EVK<\/td>\nEver-Glory International Group Inc<\/td>\n3.400000<\/td>\n14795992<\/td>\n4.0964<\/td>\n0.5025<\/td>\n4.41<\/td>\n1.59<\/td>\n<\/tr>\n
TRMT<\/td>\nTremont Mortgage Trust<\/td>\n13.010000<\/td>\n3142939<\/td>\nNone<\/td>\nNone<\/td>\n19.29<\/td>\nNone<\/td>\n<\/tr>\n
APWC<\/td>\nAsia Pacific Wire & Cable Corp Ltd<\/td>\n2.567700<\/td>\n13819669<\/td>\n4.0757<\/td>\n0.2314<\/td>\n3.34<\/td>\n0.35<\/td>\n<\/tr>\n
EDGE<\/td>\nEdge Therapeutics Inc<\/td>\n1.060000<\/td>\n31246231<\/td>\nNone<\/td>\n0.7480<\/td>\n2.40<\/td>\n1.73<\/td>\n<\/tr>\n
GIGM<\/td>\nGigaMedia Ltd<\/td>\n2.960000<\/td>\n11052235<\/td>\n32.8889<\/td>\n0.5392<\/td>\n5.62<\/td>\n5.77<\/td>\n<\/tr>\n
ABAC<\/td>\nRenmin Tianli Group Inc<\/td>\n2.830000<\/td>\n9983745<\/td>\n17.0629<\/td>\n0.2993<\/td>\n6.62<\/td>\n6.40<\/td>\n<\/tr>\n
FLKS<\/td>\nFlex Pharma Inc<\/td>\n0.975000<\/td>\n18013532<\/td>\nNone<\/td>\n0.8024<\/td>\n1.22<\/td>\nNone<\/td>\n<\/tr>\n
CYCC<\/td>\nCyclacel Pharmaceuticals Inc<\/td>\n1.410000<\/td>\n11997447<\/td>\nNone<\/td>\n0.8294<\/td>\n1.81<\/td>\n0.96<\/td>\n<\/tr>\n
DARE<\/td>\nDare Bioscience Inc<\/td>\n1.175000<\/td>\n11422161<\/td>\nNone<\/td>\n0.8483<\/td>\n1.37<\/td>\n0.66<\/td>\n<\/tr>\n
CREG<\/td>\nChina Recycling Energy Corp<\/td>\n1.575000<\/td>\n8310198<\/td>\nNone<\/td>\n0.0615<\/td>\n6.40<\/td>\n0.05<\/td>\n<\/tr>\n
RTTR<\/td>\nRitter Pharmaceuticals Inc<\/td>\n2.520000<\/td>\n5019639<\/td>\nNone<\/td>\n0.9456<\/td>\n3.77<\/td>\nNone<\/td>\n<\/tr>\n
KBSF<\/td>\nKBS Fashion Group Ltd<\/td>\n4.810000<\/td>\n2271299<\/td>\nNone<\/td>\n0.0715<\/td>\n11.10<\/td>\n10.37<\/td>\n<\/tr>\n
CHFS<\/td>\nCHF Solutions Inc<\/td>\n2.100000<\/td>\n4501448<\/td>\nNone<\/td>\n0.7632<\/td>\n2.33<\/td>\n0.29<\/td>\n<\/tr>\n
NVIV<\/td>\nInVivo Therapeutics Holdings Corp<\/td>\n1.750000<\/td>\n3026749<\/td>\nNone<\/td>\n0.6364<\/td>\n3.84<\/td>\n3.59<\/td>\n<\/tr>\n<\/table>\n

Let’s look at a few companies…<\/h4>\n

Lets look at a couple of the companies on this list to get a better understanding of them.<\/p>\n

CXDC:NAS China XD Plastics Co<\/h6>\n

http:\/\/www.chinaxd.net<\/a>
\nChina XD Plastics Co has 2461 employees and is headquartered in China.
\nChina XD Plastics company Ltd manufactures plastics for automobiles. Its product includes automobile exteriors, for car interiors and other components.<\/p>\n

SCPH:NAS scPharmaceuticals<\/h6>\n

http:\/\/www.scpharmaceuticals.com<\/a>
\nscPharmaceuticals has 29 employees and is headquartered in United States.
\nscPharmaceuticals Inc is a pharmaceutical company. Its pipeline includes products in various stages of clinical and non-clinical development. It focuses on proven pharmaceutical products in the cardiovascular and infectious disease therapeutic areas.<\/p>\n

Free Valuation<\/h4>\n

Run a valuation on any of the companies listed above at www.stockcalc.com\/valureport.aspx<\/a> or subscribe at our Stockcalc Facebook Page to receive this list each day Stockcalc Reports<\/a>.<\/p>\n

The content presented here is in part from the website stockcalc.com<\/a> and is provided on an as is<\/strong> or as available<\/strong> basis with all faults and may not be current in all cases. You should not rely on any of the information as authoritative or as a substitute for the exercise of your own skill and judgment in making an investment decision.<\/em><\/p>\n

<\/div>\n
\n

Wait! We want you to try StockCalc for<\/span><\/h2>\n

5 Free Days <\/h1>\n

Yes, I want to find out what my stocks are worth<\/span><\/a>
\n No, I don’t want to know the value of my stocks<\/span><\/a>\n <\/div>\n